|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 491/052 | |
| A61K 31/4188 | |||
| A61P 31/12 |
| (11) | Patento numeris | 2850085 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13726936.1 |
| Europos patento paraiškos padavimo data | 2013-05-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/041201 |
| Data | 2013-05-15 |
| (87) | Numeris | WO 2013/173488 |
| Data | 2013-11-21 |
| (30) | Numeris | Data | Šalis |
| 201261647966 P | 2012-05-16 | US | |
| 201313831116 | 2013-03-14 | US |
| (72) |
LINK, John O., US
COTTELL, Jeromy J., US
TREJO MARTIN,Teresa Alejandra, US
BACON, Elizabeth M., US
|
| (73) |
Gilead Pharmasset LLC,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5A |
| ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5A |